BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38700533)

  • 41. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity.
    Cui J; Wang Y; Tian X; Miao Y; Ma L; Zhang C; Xu X; Wang J; Fang W; Zhang X
    Antioxid Redox Signal; 2023 Sep; 39(7-9):491-511. PubMed ID: 37166352
    [No Abstract]   [Full Text] [Related]  

  • 43. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
    Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
    Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
    [No Abstract]   [Full Text] [Related]  

  • 44. Protumor Effects of Histone H3-H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and
    Wu L; Jie B
    Comput Math Methods Med; 2021; 2021():5005459. PubMed ID: 34956399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging.
    Lu T; Qiu T; Han B; Wang Y; Sun X; Qin Y; Liu A; Ge N; Jiao W
    Cell Oncol (Dordr); 2021 Apr; 44(2):297-310. PubMed ID: 33118120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
    Liu Z; Hu Z; Cai X; Liu S
    Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Predictive Model Incorporating Ferroptosis-Related Gene Signatures for Overall Survival in Patients with Lung Adenocarcinoma.
    Wang Y; Pan Y; Wu J; Luo Y; Fang Z; Xu R; Teng W; Chen M; Li Y
    Med Sci Monit; 2022 Feb; 28():e934050. PubMed ID: 35102130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.
    Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q
    Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production.
    Fan J; Zhang X; Wang S; Chen W; Li Y; Zeng X; Wang Y; Luan J; Li L; Wang Z; Sun X; Shen B; Ju D
    Cell Death Dis; 2019 Aug; 10(9):626. PubMed ID: 31427566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DARS2 promotes the occurrence of lung adenocarcinoma via the ERK/c-Myc signaling pathway.
    Fang T; Jiang J; Yu W; Li R; Tian H
    Thorac Cancer; 2023 Dec; 14(36):3511-3521. PubMed ID: 37950542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CHPF promotes lung adenocarcinoma proliferation and anti-apoptosis via the MAPK pathway.
    Hou XM; Zhang T; Da Z; Wu XA
    Pathol Res Pract; 2019 May; 215(5):988-994. PubMed ID: 30826152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
    Wang M; Liao Q; Zou P
    Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
    Zhou J; Wang X; Li Z; Jiang R
    FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CYP2J2
    Tao P; Jiang Y; Wang H; Gao G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):932-941. PubMed ID: 34707002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SLITRK6 promotes the progression of lung adenocarcinoma by regulating PI3K/AKT/mTOR signaling and Warburg effect.
    Yu F; Zhao X; Li M; Meng M
    Apoptosis; 2023 Aug; 28(7-8):1216-1225. PubMed ID: 37219677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.
    Gao X; Tang M; Tian S; Li J; Liu W
    Future Oncol; 2021 Apr; 17(12):1533-1544. PubMed ID: 33432837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H; Zhang Z; Qing X; French SW; Liu D
    Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting PKD2 aggravates ferritinophagy-mediated ferroptosis via promoting autophagosome-lysosome fusion and enhances efficacy of carboplatin in lung adenocarcinoma.
    Liu Y; Pang Z; Wang Y; Liu J; Wang G; Du J
    Chem Biol Interact; 2024 Jan; 387():110794. PubMed ID: 37951334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.